Prevalence of the STK15 F31I polymorphism and its relationship with mammographic density

Brazilian Journal of Medical and Biological Research

Volumn 44, Issue 4, 2011, Pages 291-296

  Giacomazzi, J ^a,b,c   Aguiar, E ^a,b,c   Palmero, E I ^a,b,c,d   Schmidt, A V ^a   Skonieski, G ^c   Duarte Filho, D ^c   Bock, H ^b   Saraiva Pereira, M L ^a,b   Schuler Faccini, L ^a,b   Camey, S A ^a   Caleffi, M ^c   Giugliani, R ^a,b   Ashton Prolla, P ^a,b,c  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c HOSPITAL MOINHOS DE VENTO   (Brazil)

^d BARRETOS CANCER HOSPITAL   (Brazil)

Author keywords

Breast cancer risk; Mammographic density; STK15 F31I polymorphism

Indexed keywords

AURORA A KINASE;

ADULT; AGED; ARTICLE; BRAZIL; BREAST CANCER; CANCER RISK; DENSITY GRADIENT; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAMMOGRAPHY; MEDICAL RECORD REVIEW; MENARCHE; PREMENOPAUSE; RISK ASSESSMENT;

EID: 79955438335     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2011007500029     Document Type: Article

References (27)

1. World Health Organization Database. [http://www.who.int/infobase].
2. McPherson K, Steel CM, Dixon JM. ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. BMJ 2000; 321: 624-628.
3. Schwartsmann G. Breast cancer in South America: challenges to improve early detection and medical management of a public health problem. J Clin Oncol 2001; 19: 118S-124S.
4. Dunning AM, Healey CS, Pharoah PD, Teare MD, Ponder BA, Easton DF. A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 1999; 8: 843-854.
5. Dutertre S, Descamps S, Prigent C. On the role of Aurora-A in centrosome function. Oncogene 2002; 21: 6175-6183.
6. Ewart-Toland A, Briassouli P, de Koning JP, Mao JH, Yuan J, Chan F, et al. Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human. Nat Genet 2003; 34: 403-412.
7. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998; 396: 643-649.
8. Sun T, Miao X, Wang J, Tan W, Zhou Y, Yu C, et al. Functional Phe31Ile polymorphism in Aurora A and risk of breast carcinoma. Carcinogenesis 2004; 25: 2225-2230.
9. Dai Q, Cai QY, Shu XO, Ewart-Toland A, Wen WQ, Balmain A, et al. Synergistic effects of STK15 gene polymorphisms and endogenous estrogen exposure in the risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2004; 13: 2065-2070.
10. Cox DG, Hankinson SE, Hunter DJ. Polymorphisms of the AURKA (STK15/Aurora Kinase) Gene and Breast Cancer Risk (United States). Cancer Causes Control 2006; 17: 81-83.
11. Egan KM, Newcomb PA, Ambrosone CB, Trentham-Dietz A, Titus-Ernstoff L, Hampton JM, et al. STK15 polymorphism and breast cancer risk in a population-based study. Carcinogenesis 2004; 25: 2149-2153. Erratum: Carcinogenesis 2005; 26: 701.
12. Chambo D, Kemp C, Costa AM, Souza NC, Guerreiro da Silva I. Polymorphism in CYP17, GSTM1 and the progesterone receptor genes and its relationship with mammographic density. Braz J Med Biol Res 2009; 42: 323-329.
13. Caleffi M, Ashton-Prolla P, Weber B, Zignani JM, Dias EC, Antunes LP, et al. Breast cancer screening in 10.000 women of an underserved population in South Brazil: the NMAMAPOA cohort. J Clin Oncol 2005; 23: 877.
14. Smith RA, Caleffi M, Albert US, Chen TH, Duffy SW, Franceschi D, et al. Breast cancer in limited-resource countries: early detection and access to care. Breast J 2006; 12 (Suppl 1): S16-S26.
15. American College of Radiology. Illustrated breast imaging reporting and data system (BIRADS). Reston: American College of Radiology; 1998.
16. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989; 81: 1879-1886.
17. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
18. Abramson JH. WINPEPI (PEPI-for-Windows): computer programs for epidemiologists. Epidemiol Perspect Innov 2004; 1: 6.
19. Fletcher O, Johnson N, Palles C, dos Santos Silva I, McCormack V, Whittaker J, et al. Inconsistent association between the STK15 F31I genetic polymorphism and breast cancer risk. J Natl Cancer Inst 2006; 98: 1014-1018.
20. Gu J, Gong Y, Huang M, Lu C, Spitz MR, Wu X. Polymorphisms of STK15 (Aurora-A) gene and lung cancer risk in Caucasians. Carcinogenesis 2007; 28: 350-355.
21. Lo YL, Yu JC, Chen ST, Yang HC, Fann CS, Mau YC, et al. Breast cancer risk associated with genotypic polymorphism of the mitosis-regulating gene Aurora-A/STK15/BTAK. Int J Cancer 2005; 115: 276-283.
22. Price AL, Patterson N, Yu F, Cox DR, Waliszewska A, Mc-Donald GJ, et al. A genomewide admixture map for Latino populations. Am J Hum Genet 2007; 80: 1024-1036.
23. Alves-Silva J, da Silva Santos M, Guimaraes PE, Ferreira AC, Bandelt HJ, Pena SD, et al. The ancestry of Brazilian mtDNA lineages. Am J Hum Genet 2000; 67: 444-461.
24. Tavassoli FA, Devillee P. World Health Organization. Classification of tumour. Pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC Press; 2003.
25. Persson I. Estrogens in the causation of breast, endometrial and ovarian cancers-evidence and hypotheses from epidemiological findings. J Steroid Biochem Mol Biol 2000; 74: 357-364.
26. Dicioccio RA, Song H, Waterfall C, Kimura MT, Nagase H, McGuire V, et al. STK15 polymorphisms and association with risk of invasive ovarian cancer. Cancer Epidemiol Biomarkers Prev 2004; 13: 1589-1594.
27. Tchatchou S, Wirtenberger M, Hemminki K, Sutter C, Meindl A, Wappenschmidt B, et al. Aurora kinases A and B and familial breast cancer risk. Cancer Lett 2007; 247: 266-272.